News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
142,531 Results
Type
Article (7785)
Company Profile (28)
Press Release (134718)
Section
Business (42195)
Career Advice (195)
Deals (6253)
Drug Delivery (9)
Drug Development (11250)
Employer Resources (13)
FDA (3584)
Job Trends (2692)
News (63876)
Policy (4743)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 BioMidwest Digital (3)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Standard (1)
Academia (746)
Academic (1)
Allergies (11)
Alliances (14296)
ALS (11)
Alzheimer's disease (410)
Antibody-drug conjugate (ADC) (8)
Approvals (3596)
Artificial intelligence (113)
Autoimmune disease (2)
Automation (3)
Bankruptcy (54)
Best Places to Work (2242)
Biosimilars (8)
Biotechnology (16)
Bladder cancer (12)
Brain cancer (10)
Breast cancer (81)
Cancer (615)
Cardiovascular disease (28)
Career advice (174)
Career pathing (5)
CAR-T (16)
Cell therapy (41)
Cervical cancer (6)
Clinical research (8242)
Collaboration (235)
Compensation (21)
COVID-19 (653)
CRISPR (3)
C-suite (58)
Cystic fibrosis (15)
Data (401)
Decentralized trials (1)
Denatured (1)
Depression (5)
Diabetes (26)
Diagnostics (5949)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (3)
Drug discovery (32)
Drug pricing (4)
Drug shortages (2)
Duchenne muscular dystrophy (8)
Earnings (12680)
Editorial (1)
Employer branding (3)
Employer resources (12)
Events (18407)
Executive appointments (146)
FDA (3807)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (170)
Gene editing (11)
Generative AI (11)
Gene therapy (30)
GLP-1 (83)
Government (779)
Guidances (6)
Healthcare (3756)
IgA nephropathy (1)
Immunology and inflammation (14)
Indications (5)
Infectious disease (684)
Inflammatory bowel disease (22)
Influenza (13)
Intellectual property (11)
Interviews (21)
IPO (2260)
IRA (2)
Job creations (521)
Job search strategy (162)
Kidney cancer (5)
Labor market (1)
Layoffs (33)
Leadership (2)
Legal (637)
Liver cancer (15)
Lung cancer (86)
Lymphoma (43)
Machine learning (1)
Management (3)
Manufacturing (44)
MASH (8)
Medical device (2590)
Medtech (2590)
Mergers & acquisitions (4082)
Metabolic disorders (66)
Multiple sclerosis (22)
NASH (3)
Neurodegenerative disease (16)
Neuropsychiatric disorders (1)
Neuroscience (489)
NextGen: Class of 2025 (973)
Non-profit (798)
Northern California (473)
Now hiring (7)
Obesity (31)
Opinion (24)
Ovarian cancer (19)
Pain (10)
Pancreatic cancer (19)
Parkinson's disease (19)
Partnered (5)
Patents (29)
Patient recruitment (14)
Peanut (6)
People (13291)
Pharmaceutical (3)
Phase I (2975)
Phase II (3611)
Phase III (2601)
Pipeline (188)
Podcasts (5)
Policy (3)
Postmarket research (299)
Preclinical (1929)
Press Release (25)
Prostate cancer (38)
Psychedelics (2)
Radiopharmaceuticals (135)
Rare diseases (42)
Real estate (1111)
Recruiting (6)
Regulatory (3689)
Reports (12)
Research institute (873)
Resumes & cover letters (27)
Rett syndrome (1)
RNA editing (1)
Schizophrenia (4)
Series A (23)
Series B (16)
Service/supplier (2)
Sickle cell disease (2)
Southern California (362)
Spinal muscular atrophy (27)
Sponsored (6)
Startups (919)
Stomach cancer (2)
Supply chain (4)
The Weekly (4)
United States (4059)
Vaccines (62)
Venture capitalists (6)
Webinars (2)
Weight loss (12)
Women's health (7)
Worklife (1)
Date
Today (51)
Last 7 days (153)
Last 30 days (540)
Last 365 days (7027)
2025 (1741)
2024 (7219)
2023 (8639)
2022 (13150)
2021 (12767)
2020 (11726)
2019 (8303)
2018 (6341)
2017 (7160)
2016 (7021)
2015 (8119)
2014 (6023)
2013 (5311)
2012 (5635)
2011 (5957)
2010 (5231)
Location
Africa (162)
Alabama (6)
Alaska (2)
Arizona (69)
Arkansas (2)
Asia (7422)
Australia (1534)
California (1033)
Canada (337)
China (83)
Colorado (60)
Connecticut (69)
Delaware (18)
Europe (20520)
Florida (125)
Georgia (41)
Idaho (6)
Illinois (116)
India (8)
Indiana (44)
Iowa (3)
Japan (30)
Kansas (12)
Kentucky (4)
Louisiana (1)
Maine (22)
Maryland (129)
Massachusetts (661)
Michigan (75)
Minnesota (88)
Missouri (29)
Montana (4)
Nebraska (8)
Nevada (1)
New Hampshire (19)
New Jersey (227)
New Mexico (19)
New York (373)
North Carolina (205)
North Dakota (6)
Northern California (473)
Ohio (39)
Oklahoma (3)
Oregon (9)
Pennsylvania (146)
Rhode Island (4)
South America (188)
South Carolina (3)
Southern California (362)
Tennessee (26)
Texas (221)
Utah (91)
Virginia (39)
Washington D.C. (10)
Washington State (93)
Wisconsin (30)
142,531 Results for "htg molecular diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights
HTG Molecular Diagnostics, Inc., a platform-based life science tools and drug discovery company, reported financial results for the quarter ended March 31, 2023 and provided recent drug discovery business highlights.
May 10, 2023
·
10 min read
Press Releases
Molecular Diagnostics Market Size Forecasted to Hit USD 63.86 Bn By 2034
February 19, 2025
·
1 min read
Press Releases
North America Molecular Diagnostics Market Size to Hit USD 8.91 Billion by 2034
February 26, 2025
·
1 min read
Collaboration
Lilly Hops On Hot Molecular Glue Train With $1.2B+ Magnet Deal
The molecular glue space has attracted several Big Pharma players over the past few years, including Novo Nordisk, Pfizer and Novartis.
February 28, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Point-of-Care Molecular Diagnostics Market Size to Exceed USD 12.61 Billion by 2034
February 26, 2025
·
1 min read
Deals
Bruker Completes Acquisition of Molecular Diagnostics Innovator ELITech
Bruker Completes Acquisition of Molecular Diagnostics Innovator ELITech.
May 2, 2024
·
5 min read
Press Releases
Oncocytoma Market Expected to Exhibit a CAGR of 5.24% during 2025-2035, Impelled by Emerging Role of Molecular Diagnostics
February 19, 2025
·
9 min read
Biotech Bay
Alveo’s Portable, Rapid Molecular Diagnostic Platform Proves Unshakable in Rigorous Ruggedness Tests
Alveo Technologies, Inc., a leader in molecular sensing and diagnostics with its proprietary technology platform, announced the results of rigorous testing that demonstrate the ruggedness of its portable molecular testing platform.
June 18, 2024
·
3 min read
HTG Molecular Diagnostics Announces Pricing of a $10 Million Public Offering
HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG) today announced the pricing of a public offering of an aggregate of 1,290,322 shares of its common stock (or pre-funded warrants in lieu thereof), Series A-1 warrants to purchase up to 1,290,322 shares of common stock and Series A-2 warrants to purchase 1,290,322 shares of common stock, at a combined public offering price of $7.75 per share (or pre-funded warrant) and accompanying warrants.
December 21, 2022
·
4 min read
Business
HTG Molecular Diagnostics Reports Third Quarter 2022 Results
HTG Molecular Diagnostics, Inc., a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, reported financial results for the quarter ended September 30, 2022 and provided recent business highlights.
November 10, 2022
·
10 min read
1 of 14,254
Next